论文部分内容阅读
现行管理政策若想保持美国生物技术在国际市场中的竞争地位,关键仍然是要大力支持基础研究和研究培训工作。1990财年,联邦政府对生物技术研究的总投资额约35亿美元。其中80％由国立卫生研究院拨出。其中最有深远影响的项目是由卫生部和能源部支持的人类染色体组项目,旨在绘出人体所有基因位置图。这项研究将为医药、医疗装置、诊断方法和信息学提供重要的技术副产品。除了国立卫生研究院外,联邦还有11个其它执行机构在支持大有潜力的生物技术项目,
Current Management Policies The key to maintaining the competitive position of U.S. biotechnology in international markets remains the need to strongly support basic and research training. In fiscal year 1990, the federal government invested about 3.5 billion U.S. dollars in biotechnology research. 80% of which is funded by the National Institutes of Health. One of the most far-reaching projects is the Human Genome Project supported by the Ministry of Health and the Department of Energy, which aims to map all of the genes in the human body. This research will provide important technical byproducts for medicine, medical devices, diagnostic methods and informatics. In addition to the National Institutes of Health, there are 11 other implementing agencies in the Federation that support promising biotech projects,